Banco Bilbao Vizcaya Argentaria S.A. Has $2.36 Million Stake in Henry Schein, Inc. $HSIC

Banco Bilbao Vizcaya Argentaria S.A. lifted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 629.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,302 shares of the company’s stock after acquiring an additional 27,871 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Henry Schein were worth $2,359,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. JPMorgan Chase & Co. boosted its stake in Henry Schein by 6.5% in the first quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company’s stock worth $436,489,000 after purchasing an additional 390,399 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in Henry Schein by 4.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company’s stock worth $153,480,000 after buying an additional 103,384 shares in the last quarter. Burgundy Asset Management Ltd. grew its holdings in Henry Schein by 33.9% during the 1st quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company’s stock worth $153,105,000 after acquiring an additional 566,530 shares during the last quarter. Clarkston Capital Partners LLC increased its position in Henry Schein by 0.4% in the 1st quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company’s stock valued at $119,965,000 after acquiring an additional 7,345 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Henry Schein by 1.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,203,676 shares of the company’s stock valued at $82,440,000 after purchasing an additional 11,999 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HSIC has been the topic of several research reports. Evercore ISI upped their price objective on Henry Schein from $83.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, November 5th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Henry Schein in a research note on Friday, October 31st. UBS Group lowered their price objective on Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research report on Wednesday, August 6th. Wells Fargo & Company raised their target price on shares of Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 5th. Finally, Barrington Research set a $79.00 price target on Henry Schein and gave the stock an “outperform” rating in a research report on Wednesday, November 5th. Five investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein has an average rating of “Hold” and an average price target of $76.08.

Henry Schein Stock Down 2.6%

NASDAQ:HSIC opened at $71.43 on Monday. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The stock has a 50-day moving average price of $66.73 and a two-hundred day moving average price of $69.01. The stock has a market cap of $8.41 billion, a price-to-earnings ratio of 23.04, a PEG ratio of 2.06 and a beta of 0.84. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.11. The business had revenue of $3.34 billion during the quarter, compared to analyst estimates of $3.28 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. As a group, equities analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.